Short Term Trading Week Starting: 21 May, page-96

Good post Oscar09,

I too have been intrigued by RBO.

On my list of good Q on Q revenues supporting model validation.

You are correct in funding uncertainty and improvement in this area,

I group with NUH, both looking up with NUH morphing into hearing aids and being described as the next Cochlear (steady down )

My problem with stocks like this is percieved lack of IP and ease of entry concerns but maybe getting too anal about this.

Have heard more than once from people that know much more informed than I that the management team at RBO are real guns.

Anyway thanks, will have closer look at profitability timeline today.